Carol Peebles

Scientist

Carol Peebles

A Timeline of Professional Milestones 

1941

Born to Harry Alexander Peebles and Phyllis Dorothy  Peebles in Wellington, Kansas.

1962

Earns a Bachelor of Arts from Kansas State College in Pittsburg, Kansas (now Pittsburg State University).

1964

Earns a Master of Arts from Kansas State College in Pittsburg, Kansas (now Pittsburg State University).

1965

Becomes a certified medical technician with St. Francis Hospital in Wichita, Kansas.

1965

Works as a medical technologist at St. Francis Hospital (now Via Christi Hospital St. Francis) in Wichita, Kansas, until 1974.

1974

Becomes a laboratory supervisor in allergy and immunology with The Scripps Research Institute (TSRI) in La Jolla, CA, until 1977.

1975

Works within Eng M Tan, MD Laboratory, and conducts research related to the Systemic Autoimmune Rheumatic Disease Systemic sclerosis.

1977

Is a laboratory supervisor within the Rheumatology Laboratory at Health Science Center of the University of Colorado Denver until 1982.

1980

Resumes work at Eng M Tan, MD Laboratory, and conducts research related to the Systemic Autoimmune Rheumatic Disease Systemic sclerosis.

1982

Becomes a senior research assistant within the Autoimmune Disease Center at the The Scripps Research Institute (TSRI) in La Jolla, CA.

1984

Co-authors a manual on laboratory testing for Systemic Autoimmune Rheumatic Disease

1991

Continues work as a team member in Eng M Tan, MD Laboratory, and conducts research related to Systemic Autoimmune Rheumatic Disease.

1994

Works in Eng M Tan, MD Laboratory, identifies autoantibodies in patients with predominantly other than Systemic Autoimmune Rheumatic Disease.

1995

Works at  Eng M Tan, MD Laboratory, conducts research associated with cell proliferation and cancer in patients.

2001

Works as a scientist at Inova Diagnostics in San Diego, CA, where she presently remains.

2009

Authors a laboratory manual on Antinuclear Antibodies titled “Fluorescent ANAs and Beyond!” available on Google Books.

2020

Continues to participate in the discovery of autoantibodies that are important in helping researchers develop medical treatments.

 

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn